Our mission
to reduce the burden of cardiovascular disease
Welcome! To enjoy a personalised experience, sign in.
Sign inWhat's Hot!
From science to events, it’s all right here
Beyond LDL: could statins help protect against frailty?
Read the comment on the European Heart Journal article "Statins and survival free of incident frailty among older US veterans".
ESC Congress 2026 – see the programme
This year's Spotlight on Artificial Intelligence explores how AI is becoming a co-pilot, enhancing precision, speed, and safety in patient care. Discover AI in action, from diagnosis to delivery, through hands-on sessions, live demonstrations, and immersive learning.
From prescription to persistence: guideline-recommended medical therapy in heart failure with reduced ejection fraction
Listen to our latest ESC Cardio Talk podcast with Johann Bauersachs and Samira Soltani, Hannover Medical School, Hannover (Germany).
Metabolic control of post-MI fibrosis via a urea cycle–TCA axis
Read the comment on the European Heart Journal article, which explores whether SGLT2 inhibitors like dapagliflozin can directly influence cardiac fibrosis by modulating the energy metabolism of activated cardiac fibroblasts.
New Levels of Evidence for ESC Guidelines: what changed and why it matters
Join our ESC webinar on 19 June at 18:00 to explore the revised Level of Evidence framework. Gain clarity on evidence grading, key methodological principles, and what this evolution means for clinical trials and future guideline recommendations in cardiovascular care.
EHJ Dialogues
Join us on 24 June at 17:00 for an EHJ Dialogue with Prof. Ziad Mallat on the evolving landscape of anti-inflammatory strategies in atherosclerotic cardiovascular disease, moving from upstream inhibition of the NLRP3 inflammasome to downstream targeting of the IL-6 pathway and immune modulation through low-dose interleukin-2.
Transcatheter treatment of tricuspid regurgitation
Severe tricuspid regurgitation is increasingly recognised, but when should we intervene? Stephan Baldus discusses patient selection, treatment strategy, and insights from the TRISCEND II trial in the latest episode of ESC TV Today.
Editor's Choice
Discover this week's selection from Prof. Felix Mahfoud, Editor-in-Chief of the ESC website
The impact of wearables on the future of cardiovascular care.
Read the expert commentary on “Wearable devices and cardiovascular health: revolutionising remote monitoring and disease prevention” (European Heart Journal) from ESC Working Group on e-Cardiology member, Assoc. Prof. Busnatu.
Cardiovascular disease outcomes: does physician’s sex matter?
Do physician and patient gender dynamics affect cardiovascular outcomes? Edina Cenko, Elena Osto and Roxana Mehran explore in this Cardiopulse article how diversity, communication, bias and representation in cardiology may influence care quality and patient outcomes.
ESC TV Today - Carcinoid Heart Disease
What should cardiologists know about carcinoid heart disease, a rare but serious valvular condition? Who is most at risk, how does it present, and which clinical clues should raise suspicion? Heidi Connolly discusses the key red flags, diagnostic approach, and current treatment options.
Stay up to date
Great science, direct to your inbox!
Sign up for free to the My ESC News.
Congresses
Our congresses bring us together
To share knowledge, present the latest science, and shape the future of cardiovascular care.
Your Journal Selection
Explore this week's articles from the ESC Journal Family
Image of the week
Test your knowledge each week with our quick quiz and sharpen your diagnostic skills!
This week’s image was submitted by Esosa Odigie-Okon, MD, MSc, FACC, University of Texas Medical Branch, Galveston, Texas, USA.
Current episode
Expert insight
- Transcatheter treatment of tricuspid regurgitation with Stephan Baldus
- Carcinoid heart disease with Heidi Connolly
- Milestones: the MADIT-II trial
- Cardiology this Week: must-see recent trials
About the ESC
Driven by science, united for patients
We are a volunteer-led, not-for-profit medical society. Our members and decision-makers are scientists, clinicians, nurses and allied professionals working in all fields of cardiology.
We unite national cardiac societies from around the world. This unique network allows us to understand the impact of cardiovascular disease and how we can better reduce its burden. Our diversity is our strength.
Join our community
Whether you’re a student, early-career professional, or experienced cardiologist, there’s a place for you here.
From access to congress resources and webinars, to mentoring, and specialised training, you’ll be supported with tools to expand your knowledge.
Choose the membership that's right for you.
Explore our key offerings
ESC Clinical Practice Guidelines help you weigh up the benefits and risks in your decision making
2025 ESC Guidelines for the management of myocarditis and pericarditis
These guidelines introduce a comprehensive, patient-oriented framework for the diagnosis and management of IMPS, spanning the full disease spectrum.
2025 ESC Guidelines for the management of cardiovascular disease and pregnancy
The current Guidelines for the management of cardiovascular disease and pregnancy support health care professionals to manage and care for women with cardiovascular diseases before, during and after pregnancy.
2025 ESC/EACTS Guidelines for the management of valvular heart disease
The 2025 ESC/EACTS Guidelines update the 2021 valvular heart disease recommendations. Key revisions highlight the central role of the Heart Team, the importance of Heart Valve Centres, and advances in diagnostic imaging with clearer criteria for complex VHD. They also refine indications and timing for interventional options across the spectrum of VHD.
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
This 2025 Focused Update addresses changes in recommendations for the treatment of dyslipidaemias based on new evidence published since the 2019 version, up until 31 March 2025.
2025 ESC Clinical Consensus Statement on mental health and cardiovascular disease
This clinical consensus statement on mental health and cardiovascular disease highlights the multidirectional relationship between mental health, cardiovascular health and cardiovascular disease and its impact on cardiovascular risk and prognosis.
ESC Education
Your go-to destination for flexible courses
We know you're busy, so we've made it simple to develop your knowledge across three levels: Core Cardiology, Subspecialty and Expert.
Core Cardiology
Understanding and application of ESC Guidelines and preparation for the European Exam in Core Cardiology.
Specialty
Training, certification and clinical practice in cardiology subspecialties.
Experts
Continuous professional development for general cardiologists and established specialists.